Propanc Biopharma, Inc. (PPCB)
NASDAQ: PPCB · Real-Time Price · USD
1.600
-0.010 (-0.62%)
At close: Jul 13, 2026, 4:00 PM EDT
1.570
-0.030 (-1.88%)
Pre-market: Jul 14, 2026, 6:12 AM EDT
Propanc Biopharma Employees
As of June 30, 2025, Propanc Biopharma had 2 total employees, including 1 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$9,646,588
Market Cap
3.65M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2025 | 2 | 0 | - | 1 | 1 |
| Jun 30, 2024 | 2 | 0 | - | 1 | 1 |
| Jun 30, 2023 | 2 | -1 | -33.33% | 1 | 1 |
| Jun 30, 2022 | 3 | 1 | 50.00% | 1 | 2 |
| Jun 30, 2021 | 2 | -1 | -33.33% | 1 | 1 |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Virax Biolabs Group | 26 |
| GeoVax Labs | 19 |
| Decoy Therapeutics | 11 |
| Ensysce Biosciences | 10 |
| Revelation Biosciences | 9 |
| Artelo Biosciences | 7 |
| Galmed Pharmaceuticals | 6 |
| Creative Medical Technology Holdings | 4 |
PPCB News
- 6 days ago - Propanc Biopharma signs MOU with Avance Clinical for PRP clinical trial - TheFly
- 6 days ago - Propanc Biopharma Signs MOU with Avance Clinical Pty Ltd - GlobeNewsWire
- 11 days ago - Propanc Biopharma initiates share repurchase program - TheFly
- 11 days ago - Propanc Biopharma Initiates $5.0 Million Share Repurchase Program - GlobeNewsWire
- 27 days ago - Propanc CEO visits European manufacturer ahead of drug production plan - TheFly
- 27 days ago - Propanc Biopharma's CEO Tours European CDMO & Plans for GMP Production of PRP for Phase 1b, FIH Study - GlobeNewsWire
- 4 weeks ago - Propanc Biopharma announces $5M share repurchase program - TheFly
- 4 weeks ago - Propanc Biopharma Authorizes $5.0 Million Share Repurchase Program - GlobeNewsWire